A Case Report of a New Inflammatory Eye Syndrome in an Hiv Positive Patient: The Immune Restoration Uveitis

Hoggs R.S. O'Shaughnessy M.V. Gataric N. Yip B. Craib K. Schechter M.T. Montaner J.S. 1997. Decline in deaths from AIDS due to new antiretrovirals. Lancet 349:1294.

Mocroft A. Ledergerber B. Katlama C. Kirk O. Reiss P. Monforte A. d'Arminio Knysz B. Dietrich M. Phillips A.N. Lundgren J.D. for the EuroSIDA study group. 2003. Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet 362:22.

Palella F.J. Delaney K.M. Moorman A.C. Loveless M.O. Fuhrer J. J. Satten G.A. Aschman D.J. Holmberg S.D. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853.

French M.A. Lenzo N. John M. Mallal S.A. McKinnon E.J. James I.R. Price P. Flexman J.P. Tay-Kearney M.L. 2000. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med. 1:107.

Shelburne S.A. Hamill R.J. 2003. The immune reconstitution inflammatory syndrome. AIDS Rev. 5:67.

Hung C.C. Chang S.C. 2004. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J. Antimicrob. Chemother. 54:849.

Grunfeld C. Tien P. 2003. Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome. Clin. Infect. Dis. 37:43.

Stoll M. Schmidt R.E. 2003. Immune restoration inflammatory syndromes: The dark side of successful antiretroviral treatment. Curr. Infect. Dis. Rep. 5:266.

Pertel P. Hirschtick R. Phair J. Chmiel J. Poggensee L.L. Murphy R. 1992. Risk of developing cytomegalovirus retinitis in persons with the human immunodeficiency virus. J. Acquir. Immune Def. Syndr. 5:1069.

Holland G.N. Pepose J.S. Pettit T.H. Gottlieb M.S. Yee R.D. Foos R.Y. 1983. Acquired immune deficiency syndrome: Ocular manifestations. Ophthalmol. 90:859.

Kuppermann B.D. Petty J.C. Richman D.D. Mathews W.C. Fullerton S.C. Rickman L.S. Freeman W.R. 1993. Correlations between CD4+ counts and prevalence of cytomegalovrus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am. J. Ophthalmol. 115:575.

Whitcup S.M. 2000. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA 283:653.

Cheung T.W. Teich S.A. 1999. Cytomegalovirus infection in patients with HIV infection. Mt. Sinai J. Med. 66:113.

Mitchell S.M. Membrey W.L. Youle M.S. Obi A. Worrell S. Gazzard B.G. 1999. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: A 2 years prospective study. Br. J. Ophthalmol. 83:652.

Whitley R.J. Jacobson M.A. Friedberg D.N. Holland G.N. Jabs D.A. Dieterich D.T. Hardy W.D. Polis M.A. Deutsch T.A. Feinberg J. Spector S.A. Walmsley S. Drew W.L. Powderly W.G. Griffiths P.D. Benson C.A. Kessler H.A. 1998. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy. Arch. Intern. Med. 158:957.

Jabs D.A. Bolton S.G. Dunn J.P. Palestine A.G. 1998. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination therapy. Am. J. Ophthalmol. 126:817.

Holland G.N. 1999. Immune recovery uveitis. Ocul. Immunol. Inflamm. 7:215.

Karavellas M.P. Lowder C.Y. MacDonald J.C. Avila C.P. Freeman W.R. 1998. Immune recovery vitritis associated with inactive cytomegalovirus retinitis. JAMA 116:169.

Van der Horn G.J. Meenken C. Danner S.A. Reiss P. de Smet M.D. 1999. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients. Br. J. Ophthalmol. 82:988.

Gariano R.F. Cooney E.L. 1997. Uveitis following administration of the protease inhibitor indinavir to a patient with AIDS. Clin. Infect. Dis. 24:529.

Bouza E. Merino P. Munoz P. P. Sanchez-Carrillo C. Yanez J. Cortes C. C. 1997. Ocular tuberculosis: A prospective study in a general hospital. Medicine 76:53.

Ruder A.J. Halverson K.D. Austin J.K. Jones W.L. 1993. Neurosyphilis with associated retinitis. J. Am. Optom. Assoc. 64:245.

Komanduri K.V. Viswanathan M.N. Wieder E.D. Schmidt D.K. Bredt B. M. Jacobson M.A. McCune J.M. 1998. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after gancyclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat. Med. 4:953.

Karavellas M.P. Plummer D.J. MacDonald C. Shufelt C.L. Lowder C.Y.CY Plummer D.J. Glasgow BB. Torriani F.J. Freeman W.R. 1999. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J. Infect. Dis. 179:697.

Cassoux N. Lumbroso L. Bodaghi B. B. Zazoun L. Katlama C. LeHoang P. 1999. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy. Br. J. Ophthalmol. 83:47.

Maguire A.M. Nichols C.W. Crooks G.W. 1996. Visual loss in cytomegalovirus retinitis caused by cystoid macular oedema in patients without the acquired immunodeficiency syndrome. Ophthalmol. 103:601.

Foudraine N.A. Hovenkamp E. Notermans D.W. Meenhorst P.L. Klein M.R. Lange J.M. Miedema F. Reiss P. 1999. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177.

French M.A. Price P. Stone S.F. 2004. Immune restoration disease after antiretroviral therapy. AIDS 18:1615.